Michael Pro is an Ophthalmology physician affiliated with Thomas Jefferson University. OpenAlex indexes 65 publications with 619 citations (h-index 13); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Presidential Blvd Ste 200
Bala Cynwyd, PA 190041108
Telephone
484-434-2700Provider last certified this registry record 4 Nov 2020.
Clinical trials
- Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Sponsor: Aeon Astron Europe B.V.
- Lucentis Versus Mitomycin C During Glaucoma Surgery
Sponsor: Wills Eye
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NEW WORLD MEDICAL,INC.Program year202510 payments$13,901openpaymentsdata.cms.gov ↗
- Sight Sciences, Inc.Program year20257 payments
- Glaukos CorporationProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
89.6%Prostaglandin Analog29.9%Latanoprost73%Lumigan21%Travoprost4%Tafluprost2%Part D≥398 patientsCarbonic Anhydrase Inhibitor26.6%Dorzolamide-Timolol64%Dorzolamide Hcl25%Simbrinza5%Brinzolamide5%Acetazolamide2%Part D≥307 patients+ 7 more classes in this area
Cardiovascular
7.9%Beta blocker7.9%Timolol Maleate100%Part D≥161 patientsAnti-infectives
0.9%Macrolide0.7%Erythromycin100%Part D≥21 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.2%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of outcomes of continuous-wave and micropulse trans-scleral cyclophotocoagulation: A retrospective cohort study
European Journal of Ophthalmology
2025 - Impact of Postoperative Intraocular Pressure Spikes on Outcomes Following Goniotomy: A Comparative Study of Surgical Techniques
JOURNAL OF CURRENT GLAUCOMA PRACTICE
2025 - Intraocular pressure profile following selective laser trabeculoplasty in pigmentary and primary open-angle glaucoma
European Journal of Ophthalmology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”